Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani

This publication has 28 references indexed in Scilit:

• Subunit Vaccination of Mice against New World Cutaneous Leishmaniasis: Comparison of Three Proteins Expressed in Amastigotes and Six Adjuvants
  Infection and Immunity, 2000
• Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmaniadonovani
  Vaccine, 1999
• Long-term protection of mice against Leishmania major with a synthetic peptide vaccine
  Vaccine, 1999
• Saponin adjuvant primes for a dominant interleukin‐10 production to ovalbumin and to Trypanosoma cruzi antigen
  Immunology, 1996
• Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in mice that are similar to those generated by experimental infection
  Vaccine, 1995
• Null mutants for the lmcpa cysteine proteinase gene in Leishmania mexicana
  Molecular and Biochemical Parasitology, 1994
• The Control of the Antibody Isotype Response to Recombinant Human Immunodeficiency Virus gp120 Antigen by Adjuvants
  AIDS Research and Human Retroviruses, 1992
• Adjuvanticity and ISCOM formation by structurally diverse saponins
  Vaccine, 1992
• Adjuvant Requirements for Protective Immunization of Mice Using a Trypanosoma cruzi 90K Cell Surface Glycoprotein
  International Archives of Allergy and Immunology, 1984
• A comparison of saponin with other adjuvants for the potentiation of protective immunity by a killedPlasmodium yoeliivaccine in the mouse
  Parasite Immunology, 1982